Our Recommendations
- Diagnosis and Clinical Management of Chagas Disease (2022)
- Chagas Coalition Resource Platform (2022)
- Decálogo básico sobre la atención de la enfermedad de Chagas en edades pediátricas (2022)
- Guidelines for the diagnosis and treatment of Chagas disease (2019)
- Chronic Care for Neglected Infectious Diseases: Leprosy/ Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease (2021)
New Publications
- Operational manual on indoor residual spraying: Control of vectors of malaria, Aedes-borne diseases, Chagas disease, leishmaniases and lymphatic filariasis (2024)
- Vigilancia y Control de Vectores de Importancia en Salud Pública (2024)
- 18vo. Curso Internacional de Dengue y otros Arbovirus emergentes (2025)
- Human African Trypanosomiasis (2025)
- BuDb: A Curated Drug Discovery Database for Buruli Ulcer (2022)
Filter
200
Featured
Recommendations
7
New Publications
1
Language
Document type
Studies & Reports
61
Resource Platforms
32
Fact sheets
31
Guidelines
30
Videos
13
Manuals
9
Brochures
6
Infographics
4
Dashboards/Maps
3
Strategic & Response Plan
3
No document type
3
Training Material
2
Online Courses
2
App
1
Countries / Regions
Global
19
Latin America and the Carribbean
17
Colombia
13
Argentina
7
Bolivia
4
Brazil
4
Mexico
3
Paraguay
3
El Salvador
2
Guatemala
2
Chile
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
37
Clinical Guidelines
11
Public Health
2
Capacity Building
1
Key Resources
1
Fluxograma para investigação epidemiológica da doença de Chagas
Enfermedad de Chagas e inmunosupresión. Decálogo para la prevención, el diagnóstico y el tratamiento
Según las estimaciones, en las Américas hay entre 6 y 8 millones de personas con infección por T. cruzi, con aproximadamente 30 000 casos nuevos por año por transmisión vectorial, y 8000 casos nuevos anuales por transmisión congénita. Es decir, cerca de 65 millones de personas viven en la Reg...
Aprendiendo sobre el Chagas para mejorar el acceso al diagnóstico y
tratamiento de la enfermedad.
Transmission of Chagas disease (CD) has decreased in recent decades, but the disease remains an important problem in endemic areas. There was an increase in the proportion of nonvector transmission, mainly in nonendemic countries. The aim of this study was to gather evidence concerning healthcare pr...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to address
the many outstanding rese...
Guía de Líderes comunitaros
J Clin Med . 2020 May 18;9(5):1517. doi: 10.3390/jcm9051517.
Chagas disease (CD) is a major burden in Latin America, expanding also to non-endemic countries. A gold standard to detect the CD causing pathogen Trypanosoma cruzi is currently not available. Existing real time polymerase chain reaction...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
ev Panam Salud Publica. 2020;44;e28. https://doi.org/10.26633/RPSP.2020.28
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities,
or concerning the delimitation of its fr...
Chagas disease, or American trypanosomiasis, is a condition that causes gradual organ damage. Without treatment, it can be fatal.
This article explains where the T. cruzi parasite is most common and how it can spread. It also outlines the symptoms of Chagas disease and the treatment options avail...
The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks al...
eLife 2020;9:e52072. The Triatominae are vectors for Trypanosoma cruzi, the aetiological agent of the neglected tropical Chagas disease. Their distribution stretches across Latin America, with some species occurring outside of the Americas. In particular, the cosmopolitan vector, Triatoma rubrofasci...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been compromised by gaps...
In areas of Mexico, Central America, and South America, where the Trypanosoma cruzi parasite is present in triatomine bugs, improved housing and spraying insecticide inside housing to eliminate the bugs has significantly decreased the spread of Chagas disease. Screening of blood donations for Chagas...
La enfermedad de Chagas, también llamada tripanosomiasis americana, sigue siendo endémica en 21 países de América Latina. Sin embargo, como consecuencia de las migraciones, la urbanización, la intensificación del turismo, la modificación de las estrategias agrícolas y el cambio climático, l...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
PLoS Negl Trop Dis 13(10): e0007694. In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Developmen...
La enfermedad de Chagas es parasitaria y afecta a más de 6 millones
de personas en el mundo. Como normalmente es asintomática durante
años, los nuevos casos suelen no detectarse ni reportarse y la mayoría
de las personas con la enfermedad no tiene conciencia de su condición.
Se diagnostica ...
